Skip to main content

Abstract

Not many disorders raise debate and questioning as fibromyalgia (FM).

Although FM has classification criteria many physicians worldwide doubt the existence of FM as a distinct clinical entity. This pain syndrome characterized by diffuse symmetric muscular pain has no distinct biological marker, coexist with multiple psychiatric and organic disorders and often develops secondary or subsequent to another established disease.

The following review will elaborate on the basic clinical characteristics of FM, will cover and question the considerations behind the currently used classification criteria and discuss the various scales and scoring systems that are used in order to assess the severity of this syndrome.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 219.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 279.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 379.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995; 38(1): 19–28.

    Article  CAS  PubMed  Google Scholar 

  2. Goldenberg DL, Burckhardt C, Crofford L. Management of fibromyalgia syndrome. JAMA 2004; 292(19): 2388–95.

    Article  CAS  PubMed  Google Scholar 

  3. Buskila D. Fibromyalgia, chronic fatigue syndrome, and myofascial pain syndrome 4. Curr Opin Rheumatol 1999; 11(2): 119–26.

    Article  CAS  PubMed  Google Scholar 

  4. Abeles AM, Pillinger MH, Solitar BM, Abeles M. Narrative review: The pathophysiology of fibromyalgia. Ann Intern Med 2007; 146(10): 726–34.

    PubMed  Google Scholar 

  5. Amital D, Fostick L, Polliack ML et al. Posttraumatic stress disorder, tenderness, and fibromyalgia syndrome: Are they different entities? 1. J Psychosom Res 2006; 61(5): 663–9.

    Article  PubMed  Google Scholar 

  6. Clauw DJ. Fibromyalgia: Update on mechanisms and management. J Clin Rheumatol 2007; 13(2): 102–9.

    Article  PubMed  Google Scholar 

  7. Anderberg UM, Marteinsdottir I, Theorell T, von KL. The impact of life events in female patients with fibromyalgia and in female healthy controls 75. Eur Psychiatry 2000; 15(5): 295–301.

    Article  CAS  PubMed  Google Scholar 

  8. Goldenberg DL. Fibromyalgia syndrome. An emerging but controversial condition. JAMA 1987; 257(20): 2782–7.

    Article  CAS  PubMed  Google Scholar 

  9. Wolfe F, Smythe HA, Yunus MB et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990; 33(2): 160–72.

    Article  CAS  PubMed  Google Scholar 

  10. Stratz T, Fiebich B, Haus U, Muller W. Influence of tropisetron on the serum substance P levels in fibromyalgia patients 7. Scand J Rheumatol Suppl 2004; (119): 41–3.

    Article  CAS  PubMed  Google Scholar 

  11. Vierck CJ, Jr. Mechanisms underlying development of spatially distributed chronic pain (fibromyalgia). Pain 2006; 124(3): 242–263.

    Article  PubMed  Google Scholar 

  12. Cleeland CS, Ryan KM. Pain assessment: Global use of the Brief Pain Inventory. Ann Acad Med Singapore 1994; 23(2): 129–38.

    CAS  Google Scholar 

  13. Perrot S, Dumont D, Guillemin F, Pouchot J, Coste J. Quality of life in women with fibromyalgia syndrome: Validation of the QIF, the French version of the fibromyalgia impact questionnaire. J Rheumatol 2003; 30(5): 1054–9.

    PubMed  Google Scholar 

  14. Littlejohn GO. A database for fibromyalgia. Rheum Dis Clin North Am 1995; 21(2): 527–57.

    CAS  PubMed  Google Scholar 

  15. Ware JE, Jr., Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30(6): 473–83.

    Article  PubMed  Google Scholar 

  16. Burckhardt CS, Clark SR, Bennett RM. The fibromyalgia impact questionnaire: Development and validation. J Rheumatol 1991; 18(5): 728–33.

    CAS  PubMed  Google Scholar 

  17. Harth M, Nielson WR. The fibromyalgia tender points: Use them or lose them? A brief review of the controversy. J Rheumatol 2007; 34(5): 914–22.

    PubMed  Google Scholar 

  18. Khostanteen I, Tunks ER, Goldsmith CH, Ennis J. Fibromyalgia: can one distinguish it from simulation? An observer-blind controlled study. J Rheumatol 2000; 27(11): 2671–6.

    CAS  PubMed  Google Scholar 

  19. Arnold LM, Lu Y, Crofford LJ et al. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder 11. Arthritis Rheum 2004; 50(9): 2974–84.

    Article  CAS  PubMed  Google Scholar 

  20. Arnold LM, Goldenberg DL, Stanford SB et al. Gabapentin in the treatment of fibromyalgia: A randomized, double-blind, placebo-controlled, multicenter trial 2. Arthritis Rheum 2007; 56(4): 1336–44.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Humana Press, a part of Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Yoav, A., Zamir, D., Daniela, A., Howard, A. (2008). Fibromyalgia Syndrome. In: Shoenfeld, Y., Cervera, R., Gershwin, M.E. (eds) Diagnostic Criteria in Autoimmune Diseases. Humana Press. https://doi.org/10.1007/978-1-60327-285-8_40

Download citation

Publish with us

Policies and ethics